LISATA THERAPEUTICS, INC. (LSTA) › Operating IncomeLISATA THERAPEUTICS, INC. (LSTA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$25.85M2011: -$34.00M2012: -$30.39M2013: -$36.81M2014: -$57.74M2015: -$113.85M2016: -$29.50M2017: -$27.59M2018: -$16.99M2019: -$20.09M2020: -$19.14M2021: -$29.05M2022: -$57.60M2023: -$25.71M2024: -$22.41M2025: -$18.21M-$18.21M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$18.21M+18.7%2024-$22.41M+12.8%2023-$25.71M+55.4%2022-$57.60M-98.3%2021-$29.05M-51.7%2020-$19.14M+4.7%2019-$20.09M-18.3%2018-$16.99M+38.4%2017-$27.59M+6.5%2016-$29.50M+74.1%2015-$113.85M-97.2%2014-$57.74M-56.9%2013-$36.81M-21.1%2012-$30.39M+10.6%2011-$34.00M-31.5%2010-$25.85M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share